Immunotherapy-Induced Hypophysitis: A Patient Guide
At a Glance
Immunotherapy-induced hypophysitis can reduce pituitary signals that control cortisol and other hormones. Daily replacement, a personalized sick-day plan, emergency preparation, and endocrinology follow-up can help prevent adrenal crisis while cancer treatment is coordinated safely.
Immunotherapy-induced hypophysitis (IIH) occurs when your body’s immune system, activated by cancer-fighting drugs, mistakenly attacks your pituitary gland. This tiny organ at the base of your brain acts as a command center, sending out signals that tell your other glands how to regulate vital functions like metabolism, blood pressure, and your response to stress. When the immune system causes inflammation in this gland, those signals can be disrupted or stopped entirely, leading to a drop in essential hormones [1][2].
The most critical consequence of this condition is the loss of cortisol, often called the “stress hormone.” Without enough cortisol, your body cannot maintain its blood pressure or energy balance during illness or injury, which can lead to a life-threatening emergency known as an adrenal crisis. Because of this risk, managing IIH requires you to be vigilant about symptoms like extreme fatigue, nausea, or dizziness. Protecting yourself involves more than just daily hormone replacement; it requires a specialized safety plan known as “sick day rules,” where you temporarily increase your medication during times of physical stress to mimic the body’s natural response [3][4].
While a diagnosis of hypophysitis represents a new health challenge, it is one that can be managed successfully. For most patients, the damage to the cells that signal cortisol production is long-term, meaning you will likely need to take daily hormone replacement medication for the foreseeable future. Other hormone systems, like the thyroid or gonadal axes, may eventually recover, but you will need regular monitoring by an endocrinologist to know for sure. Importantly, this diagnosis does not usually mean you have to permanently stop your cancer treatment. Many people are able to stabilize their hormone levels and safely continue the immunotherapy that is working against their cancer, provided they have a strong partnership with their medical team [5][6].
Living with IIH is about finding a new rhythm and being prepared. By wearing a medical alert bracelet, carrying an emergency injection kit, and strictly following your personalized sick-day plan, you can significantly reduce the risks associated with the condition. This guide is designed to help you move from the initial shock of diagnosis toward a place of confidence, where you have the tools and knowledge to manage your hormone health while staying focused on your primary goal of fighting cancer [7][8].
In this guide
6 chapters
Understanding Immunotherapy-Induced Hypophysitis
Learn how immunotherapy-induced hypophysitis causes hormone deficiencies, how doctors diagnose it, and how hormone replacement and sick-day rules protect you.
Symptoms and Emergency Warning Signs
Learn immunotherapy-induced hypophysitis warning signs, including adrenal crisis symptoms such as vomiting, fainting, low blood pressure, and confusion.
Diagnosis and the Normal MRI Trap
Learn how immunotherapy-induced hypophysitis is diagnosed with 8 AM cortisol, ACTH, Free T4, MRI, and cosyntropin testing—even when scans look normal.
Standard of Care Treatment and Hormone Replacement
Learn how immunotherapy-induced hypophysitis is treated with hormone replacement, adrenal crisis care, thyroid safety, and guidance on restarting cancer therapy
Impact on Your Cancer Immunotherapy
Learn when immunotherapy can restart after immune-related hypophysitis, how hormone replacement supports treatment, and when it may need to stop permanently.
Long-Term Management and Sick Day Rules
Learn long-term care and sick-day rules for immunotherapy-induced hypophysitis, including steroid stress dosing, emergency injections, monitoring, travel safety.
Common questions in this guide
What is immunotherapy-induced hypophysitis?
Why is low cortisol dangerous with hypophysitis?
What are sick-day rules for immunotherapy-induced hypophysitis?
Will I need hormone replacement permanently?
Can I continue cancer immunotherapy after developing hypophysitis?
How can I prepare for an adrenal crisis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How will we coordinate care between my oncology team and an endocrinologist?
- 2.Who should I call first if I feel a sudden 'crash' in my energy or start feeling nauseated?
- 3.What is the best way to explain this condition to my family so they know how to help me in an emergency?
- 4.Does my current hormone replacement plan adequately cover me for the next round of immunotherapy?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (8)
- 1
Immune Checkpoint Inhibitor-Related Hypophysitis and Pituitary Dysfunction: A Systematic Review of Diagnosis and Management.
SirDeshpande P, Hegde SBS, Akhtar H
Cureus 2025; (17(12)):e98717 doi:10.7759/cureus.98717.
PMID: 41510421 - 2
Immune Checkpoint Inhibitors and Associated Pituitary Dysfunctions: A Mini-Review.
Fukuda I
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2023; (90(2)):149-156 doi:10.1272/jnms.JNMS.2023_90-215.
PMID: 36823122 - 3
Diagnosis and Management of Adrenal Insufficiency and Adrenal Crisis in the Emergency Department.
Lentz S, Collier KC, Willis G, Long B
The Journal of emergency medicine 2022; (63(2)):212-220 doi:10.1016/j.jemermed.2022.06.005.
PMID: 36038436 - 4
Adrenal insufficiency.
Husebye ES, Pearce SH, Krone NP, Kämpe O
Lancet (London, England) 2021; (397(10274)):613-629 doi:10.1016/S0140-6736(21)00136-7.
PMID: 33484633 - 5
Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management.
Kotwal A
Current opinion in endocrinology, diabetes, and obesity 2021; (28(4)):427-434 doi:10.1097/MED.0000000000000652.
PMID: 34183541 - 6
The side effects of immune checkpoint inhibitor therapy on the endocrine system.
Goyal I, Pandey MR, Sharma R, et al.
The Indian journal of medical research 2021; (154(4)):559-570 doi:10.4103/ijmr.IJMR_313_19.
PMID: 35435341 - 7
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.
Bornstein SR, Allolio B, Arlt W, et al.
The Journal of clinical endocrinology and metabolism 2016; (101(2)):364-89 doi:10.1210/jc.2015-1710.
PMID: 26760044 - 8
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns.
Nguyen H, Shah K, Waguespack SG, et al.
Endocrine-related cancer 2021; (28(7)):419-431.
PMID: 33890870
This guide explains immunotherapy-induced hypophysitis and hormone-safety planning for informational purposes only and does not replace medical advice. Follow the sick-day and emergency plan made with your oncology and endocrinology teams.
Get notified when new evidence is published on Immunotherapy induced hypophysitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.